Logo image of MCFT

MASTERCRAFT BOAT HOLDINGS IN (MCFT) Stock Fundamental Analysis

NASDAQ:MCFT - US57637H1032 - Common Stock

23.47 USD
+0.39 (+1.69%)
Last: 9/8/2025, 12:21:09 PM
Fundamental Rating

6

MCFT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 33 industry peers in the Leisure Products industry. MCFT has an excellent financial health rating, but there are some minor concerns on its profitability. MCFT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

MCFT had positive earnings in the past year.
In the past year MCFT had a positive cash flow from operations.
In the past 5 years MCFT has always been profitable.
Each year in the past 5 years MCFT had a positive operating cash flow.
MCFT Yearly Net Income VS EBIT VS OCF VS FCFMCFT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

MCFT has a better Return On Assets (2.71%) than 72.73% of its industry peers.
Looking at the Return On Equity, with a value of 3.84%, MCFT is in the better half of the industry, outperforming 75.76% of the companies in the same industry.
MCFT has a better Return On Invested Capital (4.78%) than 66.67% of its industry peers.
MCFT had an Average Return On Invested Capital over the past 3 years of 16.91%. This is significantly above the industry average of 7.82%.
The 3 year average ROIC (16.91%) for MCFT is well above the current ROIC(4.78%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.71%
ROE 3.84%
ROIC 4.78%
ROA(3y)8.21%
ROA(5y)12.91%
ROE(3y)14.66%
ROE(5y)27.33%
ROIC(3y)16.91%
ROIC(5y)25.25%
MCFT Yearly ROA, ROE, ROICMCFT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100 150

1.3 Margins

MCFT's Profit Margin of 2.48% is fine compared to the rest of the industry. MCFT outperforms 72.73% of its industry peers.
MCFT's Profit Margin has declined in the last couple of years.
The Operating Margin of MCFT (4.18%) is better than 60.61% of its industry peers.
In the last couple of years the Operating Margin of MCFT has declined.
MCFT has a worse Gross Margin (20.01%) than 69.70% of its industry peers.
In the last couple of years the Gross Margin of MCFT has remained more or less at the same level.
Industry RankSector Rank
OM 4.18%
PM (TTM) 2.48%
GM 20.01%
OM growth 3Y-38.83%
OM growth 5Y-12.61%
PM growth 3Y-35.11%
PM growth 5YN/A
GM growth 3Y-8.61%
GM growth 5Y-0.74%
MCFT Yearly Profit, Operating, Gross MarginsMCFT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MCFT is still creating some value.
The number of shares outstanding for MCFT has been reduced compared to 1 year ago.
The number of shares outstanding for MCFT has been reduced compared to 5 years ago.
MCFT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MCFT Yearly Shares OutstandingMCFT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
MCFT Yearly Total Debt VS Total AssetsMCFT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

MCFT has an Altman-Z score of 5.26. This indicates that MCFT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MCFT (5.26) is better than 81.82% of its industry peers.
MCFT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.26
ROIC/WACC0.46
WACC10.49%
MCFT Yearly LT Debt VS Equity VS FCFMCFT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

MCFT has a Current Ratio of 1.86. This is a normal value and indicates that MCFT is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.86, MCFT perfoms like the industry average, outperforming 48.48% of the companies in the same industry.
A Quick Ratio of 1.39 indicates that MCFT should not have too much problems paying its short term obligations.
The Quick ratio of MCFT (1.39) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.39
MCFT Yearly Current Assets VS Current LiabilitesMCFT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

4

3. Growth

3.1 Past

The earnings per share for MCFT have decreased strongly by -21.37% in the last year.
The Earnings Per Share has been decreasing by -6.97% on average over the past years.
MCFT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.47%.
The Revenue has been decreasing by -4.78% on average over the past years.
EPS 1Y (TTM)-21.37%
EPS 3Y-41.35%
EPS 5Y-6.97%
EPS Q2Q%1100%
Revenue 1Y (TTM)-22.47%
Revenue growth 3Y-23.77%
Revenue growth 5Y-4.78%
Sales Q2Q%18.36%

3.2 Future

Based on estimates for the next years, MCFT will show a very strong growth in Earnings Per Share. The EPS will grow by 30.67% on average per year.
The Revenue is expected to grow by 10.51% on average over the next years. This is quite good.
EPS Next Y33.93%
EPS Next 2Y30.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.14%
Revenue Next 2Y10.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCFT Yearly Revenue VS EstimatesMCFT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
MCFT Yearly EPS VS EstimatesMCFT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.51, MCFT can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of MCFT indicates a somewhat cheap valuation: MCFT is cheaper than 63.64% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.02. MCFT is around the same levels.
A Price/Forward Earnings ratio of 19.05 indicates a rather expensive valuation of MCFT.
MCFT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MCFT is cheaper than 63.64% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.66, MCFT is valued at the same level.
Industry RankSector Rank
PE 25.51
Fwd PE 19.05
MCFT Price Earnings VS Forward Price EarningsMCFT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

66.67% of the companies in the same industry are more expensive than MCFT, based on the Enterprise Value to EBITDA ratio.
72.73% of the companies in the same industry are more expensive than MCFT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.77
EV/EBITDA 12.1
MCFT Per share dataMCFT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MCFT has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as MCFT's earnings are expected to grow with 30.67% in the coming years.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y30.67%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MCFT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MASTERCRAFT BOAT HOLDINGS IN

NASDAQ:MCFT (9/8/2025, 12:21:09 PM)

23.47

+0.39 (+1.69%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)08-27 2025-08-27/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners94.83%
Inst Owner Change0.96%
Ins Owners1.9%
Ins Owner Change3.23%
Market Cap389.84M
Analysts74.55
Price Target23.97 (2.13%)
Short Float %7.37%
Short Ratio9.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)92.58%
Min EPS beat(2)69.69%
Max EPS beat(2)115.47%
EPS beat(4)4
Avg EPS beat(4)1616.89%
Min EPS beat(4)69.69%
Max EPS beat(4)5970.61%
EPS beat(8)8
Avg EPS beat(8)835.03%
EPS beat(12)12
Avg EPS beat(12)563.28%
EPS beat(16)16
Avg EPS beat(16)425.3%
Revenue beat(2)1
Avg Revenue beat(2)5.22%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)10.99%
Revenue beat(4)3
Avg Revenue beat(4)4.34%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)10.99%
Revenue beat(8)7
Avg Revenue beat(8)3.77%
Revenue beat(12)11
Avg Revenue beat(12)3.19%
Revenue beat(16)11
Avg Revenue beat(16)1.43%
PT rev (1m)27.72%
PT rev (3m)22.4%
EPS NQ rev (1m)-15.08%
EPS NQ rev (3m)-30.07%
EPS NY rev (1m)1.94%
EPS NY rev (3m)-4.13%
Revenue NQ rev (1m)-7.33%
Revenue NQ rev (3m)-12.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.88%
Valuation
Industry RankSector Rank
PE 25.51
Fwd PE 19.05
P/S 1.37
P/FCF 14.77
P/OCF 10.95
P/B 2.13
P/tB 3.17
EV/EBITDA 12.1
EPS(TTM)0.92
EY3.92%
EPS(NY)1.23
Fwd EY5.25%
FCF(TTM)1.59
FCFY6.77%
OCF(TTM)2.14
OCFY9.13%
SpS17.11
BVpS11.04
TBVpS7.41
PEG (NY)0.75
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.71%
ROE 3.84%
ROCE 6.11%
ROIC 4.78%
ROICexc 8.08%
ROICexgc 16.96%
OM 4.18%
PM (TTM) 2.48%
GM 20.01%
FCFM 9.29%
ROA(3y)8.21%
ROA(5y)12.91%
ROE(3y)14.66%
ROE(5y)27.33%
ROIC(3y)16.91%
ROIC(5y)25.25%
ROICexc(3y)20.83%
ROICexc(5y)30.89%
ROICexgc(3y)32.17%
ROICexgc(5y)53.8%
ROCE(3y)21.58%
ROCE(5y)32.23%
ROICexcg growth 3Y-42.36%
ROICexcg growth 5Y-20.84%
ROICexc growth 3Y-46.96%
ROICexc growth 5Y-13.97%
OM growth 3Y-38.83%
OM growth 5Y-12.61%
PM growth 3Y-35.11%
PM growth 5YN/A
GM growth 3Y-8.61%
GM growth 5Y-0.74%
F-Score7
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 96.02%
Cap/Sales 3.24%
Interest Coverage 15.94
Cash Conversion 165.78%
Profit Quality 374.77%
Current Ratio 1.86
Quick Ratio 1.39
Altman-Z 5.26
F-Score7
WACC10.49%
ROIC/WACC0.46
Cap/Depr(3y)176.06%
Cap/Depr(5y)176.98%
Cap/Sales(3y)4.3%
Cap/Sales(5y)4.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.37%
EPS 3Y-41.35%
EPS 5Y-6.97%
EPS Q2Q%1100%
EPS Next Y33.93%
EPS Next 2Y30.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.47%
Revenue growth 3Y-23.77%
Revenue growth 5Y-4.78%
Sales Q2Q%18.36%
Revenue Next Year17.14%
Revenue Next 2Y10.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.68%
EBIT growth 3Y-53.37%
EBIT growth 5Y-16.79%
EBIT Next Year202.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y783.1%
FCF growth 3Y-22.86%
FCF growth 5Y10.53%
OCF growth 1Y184.81%
OCF growth 3Y-21.4%
OCF growth 5Y3.34%